| Patent application number | Description | Published |
|---|
| 20080317787 | Anti-Malaria Vaccine - There is provided, inter alia, a method for the prophylaxis of productive malaria infection in travelers to endemic regions comprising the administration of suitable amounts of a formulation comprising a | 12-25-2008 |
| 20100062028 | VACCINES FOR MALARIA - The present invention relates to a novel hybrid/fusion protein derived from the CS protein of | 03-11-2010 |
| 20100150998 | VACCINES FOR MALARIA - The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against the protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. In particular it relates to an immunogenic protein particle comprising the following monomers:
| 06-17-2010 |
| 20100272786 | VACCINE - The invention relates to a replication deficient simian adenoviral vector C7 encoding a protein comprising CS protein from | 10-28-2010 |
| 20100272788 | VACCINES FOR MALARIA - The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against the protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. Furthermore, particles with the specific ratio can be prepared by employing yeast, | 10-28-2010 |
